Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIMRAD: Nimorazole with Radiotherapy in HNSCC
NCT01950689Phase 3Completed
- Sponsor
- The Christie
- Start
- Sep 2014
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nimorazole in head and neck squamous cell carcinoma (HNSCC), sponsored by The Christie. Started Sep 2014; status: completed.
02
Drugs
nimorazole
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01950689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950689.